Inicio > SANCHEZ GARCIA, ANA MARIA DE LOS ANGELES

SANCHEZ GARCIA, ANA MARIA DE LOS ANGELES

CATEDRATICOS DE UNIVERSIDAD
Terapia Celular
 

Índice H en Web of Science: 27
Índice H en Scopus: 29
 

[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65251]], camposKey:1661-6596 2021-01-01 Cell therapy for colorectal cancer: The promise of chimeric antigen receptor (car)¿t cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58838]], camposKey:0041-1337 2021-01-01 Treatment of Degenerative Disc Disease with Allogeneic Mesenchymal Stem Cells: Long-term Follow-up Results2527, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41609]], camposKey:1931-5244 2019-01-01 A proof-of-concept clinical trial using mesenchymal stem cells for the treatment of corneal epithelial stem cell deficiency1840, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55852]], camposKey:2056-3418 2019-01-01 An elastin-like recombinamer-based bioactive hydrogel embedded with mesenchymal stromal cells as an injectable scaffold for osteochondral repair335347, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52142]], camposKey:1749-799X 2019-01-01 Autologous bone marrow expanded mesenchymal stem cells in patellar tendinopathy: protocol for a phase I/II, single-centre, randomized with active control PRP, double-blinded clinical trial00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55004]], camposKey:1043-0342 2019-01-01 New gene-editing strategy for allogeneic NKG2D-CAR T cell production00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38302]], camposKey:1010-5182 2018-01-01 Repair of maxillary cystic bone defects with mesenchymal stem cells seeded on a cross-linked serum scaffold222229, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47847]], camposKey:0961-2033 2018-01-01 Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis21612165, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47865]], camposKey:0146-0404 2017-01-01 A Randomized Controlled Trial of Cultivated Limbal Epithelial Cells Compared to Mesenchymal Stem Cells for the Treatment of Corneal Failure due to Limbal Stem Cell Deficiency00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54399]], camposKey:2530-643X 2017-01-01 ¡AY, Teodora!600, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47039]], camposKey:2373-8731 2017-01-01 Influence of HLA Matching on the Efficacy of Allogeneic Mesenchymal Stromal Cell Therapies for Osteoarthritis and Degenerative Disc Disease2050, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38304]], camposKey:0041-1337 2017-01-01 Intervertebral Disc Repair by Allogeneic Mesenchymal Bone Marrow Cells: A Randomized Controlled Trial19451951, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49997]], camposKey:2296-4185 2016-01-01 Repair of rotator cuff injury in rabbit animal model by in situ implantation of an injectable elastin-like recombinamer and allogeneic mesenchymal stem cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3546]], camposKey:2314-6133 2015-01-01 Stem Cell Therapy for Corneal Epithelium Regeneration following Good Manufacturing and Clinical Procedures00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38310]], camposKey:0041-1337 2015-01-01 Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: A randomized controlled trial16811690, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38311]], camposKey:0041-1337 2014-01-01 Treatment of knee osteoarthritis with autologous mesenchymal stem cells: Two-year follow-up results00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38315]], camposKey:0041-1337 2013-01-01 Treatment of knee osteoarthritis with autologous mesenchymal stem cells: A pilot study15351541, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38318]], camposKey:0065-2598 2012-01-01 Cell and tissue therapy in regenerative medicine89102, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9764]], camposKey:1746-0751 2012-01-01 Generation of inner ear sensory cells from bone marrow-derived human mesenchymal stem cells769783, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38319]], camposKey:0041-1337 2012-01-01 Response to "overenthusiastic interpretations of a nonetheless promising study": Facts and opinions00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=50950]], camposKey:0720-048X 2011-01-01 Clinical and haemodynamic evolution of lesions treated by means of atherectomy with SilverHawk in the femoropopliteal sector543547, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38322]], camposKey:0041-1337 2011-01-01 Intervertebral disc repair by autologous mesenchymal bone marrow cells: A pilot study822828, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47712]], camposKey:0002-8703 2010-01-01 Absence of accelerated atherosclerotic disease progression after intracoronary infusion of bone marrow derived mononuclear cells in patients with acute myocardial infarction-Angiographic and intravascular ultrasound-Results from the TErapia Celular Aplicada al Miocardio Pilot study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69425]], camposKey:1885-5857 2008-06-01 Effect of persistent microvascular obstruction on post-infarction ventricular remodeling following intracoronary bone-marrow cell transplantation: A contrast-enhanced cardiac magnetic resonance study602610, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47810]], camposKey:0300-8932 2008-01-01 Effect of persistent microvascular obstruction on post-infarction ventricular remodeling following intracoronary bone-marrow cell transplantation: A contrast-enhanced cardiac magnetic resonance study Impacto de la obstrucción microvascular persistente en el remodelado ventricular postinfarto tras el implante intracoronario de células mononucleadas de médula ósea: Un estudio de cardiorresonancia602610, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38338]], camposKey:1350-9047 2007-01-01 Cardiac repair by stem cells12581261, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38341]], camposKey:1743-4297 2006-01-01 Experimental models for cardiac regeneration00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69546]], camposKey:1885-5857 2004-03-01 Intracoronary stem cell transplantation in acute myocardial infarction201208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38347]], camposKey:0009-7330 2004-01-01 Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction742748, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47713]], camposKey:0300-8932 2004-01-01 Intracoronary stem cell transplantation in acute myocardial infarction Regeneración miocárdica mediante la implantación intracoronaria de células madre en el infarto agudo de miocardio201208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38220]], camposKey:0021-972X 2004-01-01 Multifunctional cells in human pituitary adenomas: Implications for paradoxical secretion and tumorigenesis45454552, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=14434]], camposKey:0300-8932 2004-01-01 Regeneración miocárdica mediante la implantación intracoronaria de células madre en el infarto agudo de miocardio201208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47714]], camposKey:0041-1345 2003-01-01 Results of percutaneous revascularization in cardiac allograft vascular disease19961998, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38357]], camposKey:0014-2999 1999-01-01 Effects K- and M-opioid receptor agonists on Ca2+ channels in neuroblastoma cells: Involvement of the orphan opioid receptor191198, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38358]], camposKey:0027-8424 1997-01-01 Multi-responsiveness of single anterior pituitary cells to hypothalamic-releasing hormones: A cellular basis for paradoxical secretion1413214137, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=6692]], camposKey:0953-816X 1996-01-01 Mechanisms for synchronous calcium oscillations in cultured rat cerebellar neurons192201, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40050]], camposKey:0114-5916 1995-01-01 ACE Inhibitors and Impotence: A Case Series from the Spanish Drug Monitoring System130131, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54395]], camposKey:0020-7292 1995-01-01 Metronidazole during pregnancy323324, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=1075]], camposKey:0197-8462 1994-01-01 Effects of extremely-law-frequency electromagnetic fields on ion transport in several mammalian cells579588, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54397]], camposKey:0213-4233 1994-01-01 Severe neurologic disorders and sialorrhea in an elderly patient treated with ciprofloxacine [ALTERACIONES NEUROLOGICAS GRAVES Y SIALORREA EN UN PACIENTE ANCIANO TRATADO CON CIPROFLOXACINA]450, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47715]], camposKey:0213-005X 1994-01-01 Study of the state of carriers of hemolytic streptococci B in groups A, B, C and G ESTUDIO DEL ESTADO DE PORTADOR DE ESTREPTOCOCOS BETAHEMOLITICOS DE LOS GRUPOS A, B, C Y G285288, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=1061]], camposKey:0264-6021 1993-01-01 Control of Ca2+ entry into HL60 and U937 human leukaemia cells by the filling state of the intracellular Ca2+ stores761766, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=1036]], camposKey:0031-6768 1993-01-01 The pathway for refilling intracellular Ca2+ stores passes through the cytosol in human leukaemia cells465469, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38374]], camposKey:0022-1767 1992-01-01 A monoclonal antibody that detects a specific human neutrophil antigen involved in phorbol myristate acetate- and formyl-methionyl-leucyl- phenylalanine-triggered respiratory burst161168, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=1059]], camposKey:0264-6021 1992-01-01 Agonist-evoked Ca2+ entry in human platelets: a reply343344, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39284]], camposKey:0006-3002 1992-01-01 Effects of the antithrombitic agent PCA 4230 on agonist-induced Ca2+ entry and Ca2+ release in human platelets257260, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=1054]], camposKey:0264-6021 1991-01-01 Agonist-induced Ca2+ influx into human platelets is secondary to the emptying of intracellular Ca2+ stores783789, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38375]], camposKey:0167-4889 1991-01-01 The role of intracellular acidification in calcium mobilization in human neutrophils00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38377]], camposKey:0264-6021 1990-01-01 Arachidonic acid-induced calcium influx in human platelets. Comparison with the effect of thrombin435443, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39283]], camposKey:0950-1991 1990-01-01 Retinoic acid modulation of the early development of the inner ear is associated with the control of c-fos expression10811090, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38379]], camposKey:0005-2736 1989-01-01 Effects of sodium removal on calcium mobilization and dense granule secretion induced by thrombin in human platelets367370, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=1017]], camposKey:0014-2956 1989-01-01 Intracellular Ca2+ potentiates Na+/H+ exchange and cell differentiation induced by phorbol ester in U937 cells709714, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39281]], camposKey:0014-5793 1989-01-01 Leupeptin does not affect the normal signal transduction mechanism in platelets407410, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38378]], camposKey:0006-291X 1989-01-01 Monitoring of the activation of receptor-operated calcium channels in human platelets2429, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38382]], camposKey:0300-5127 1989-01-01 Receptor-operated calcium channels in human platelets980982, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39282]], camposKey:0006-3002 1988-01-01 Thrombin-induced changes of intracellular [Ca2+] and pH in human platelets. Cytoplasmic alkalinization is not a prerequisite for calcium mobilization497500, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40026]], camposKey:0022-3751 1988-01-01 THROMBIN-INDUCED CYTOPLASMIC ALKALINIZATION IN HUMAN-PLATELETS IS NOT A PREREQUISITE FOR CA-MOBILIZATION00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47716]], camposKey:0014-5793 1987-01-01 cAMP reduces the affinity of Ca2+-triggered secretion in platelets183186, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38389]], camposKey:0034-9402 1986-01-01 Ca2+-dependent K+ transport in lymphocytes.459464, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47717]], camposKey:0014-5793 1985-01-01 Ca2+-independent secretion is dependent on cytoplasmic ATP in human platelets283286, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47718]], camposKey:0264-6021 1984-01-01 Effects of prostaglandin I2 and forskolin on the secretion from platelets evoked at basal concentrations of cytoplasmic free calcium by thrombin, collagen, phorbol ester and exogenous diacylglycerol833836, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47719]], camposKey:0264-6021 1984-01-01 Stimulus-response coupling in human platelets. Changes evoked by platelet-activating factor in cytoplasmic free calcium monitored with the fluorescent calcium indicator quin2819827, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47720]], camposKey:0028-0836 1983-01-01 Diacylglycerol and phorbol ester stimulate secretion without raising cytoplasmic free calcium in human platelets317319, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47721]], camposKey:0014-5793 1983-01-01 Trifluoperazine and chlorpromazine block secretion from human platelets evoked at basal cytoplasmic free calcium by activators of C-kinase4346, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47722]], camposKey:0167-4889 1983-01-01 Volume restoration in osmotically swollen lymphocytes does not involve changes in free Ca2+ concentration593596, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38398]], camposKey:0028-0836 1982-01-01 All-or-none response of the Ca2+-dependent K+ channel in inside-out vesicles744746, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47723]], camposKey:0004-0576 1981-01-01 Effect of nomifensine on the oxidative metabolism of rat brain 'in vitro' EFECTO DE LA NOMIFENSINA SOBRE EL METABOLISMO OXIDATIVO DE CEREBRO DE RATA 'IN VITRO'109116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54398]], camposKey:0430-0920 1980-01-01 Effect of clozapine on the oxygen. Glucose uptake and oxidative phosphorylation of rat brain in vitro691697, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38402]], camposKey:0014-5793 1980-01-01 Effects of several inhibitors on the K+ efflux induced by activation of the Ca2+-dependent channel and by valinomycin in the human red cell6568, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47724]], camposKey:0304-8616 1979-01-01 Effect of amphetamine and tyramine on oxidative metabolism of rat brain in vitro EFECTO DE ANFETAMINA Y TIRAMINA SOBRE EL METABOLISMO OXIDATIVO DE CEREBRO DE RATA IN VITRO284286, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47726]], camposKey:0304-8616 1979-01-01 Effect of certain direct-acting sympathicomimetic agents of rat brain in vitro EFECTO DE ALGUNOS FARMACOS SIMPATICOMIMETICOS DE ACCIOU DIRECTA SOBRE EL METABOLISMO OXIDATIVO DE CEREBRO DE RATA IN VITRO287289, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47725]], camposKey:0304-8616 1979-01-01 Effect of clozapine on oxygen consumption, glucose and oxidative phosphorylation of rat brain and liver in vitro EFECTO DE CLOZAPINA SOBRE CONSUMO DE OXIGENO, GLUCOSA Y FOSFORILIZACION OXIDATIVA DE CEREBRO E HIGADO DE RATA IN VITRO290292, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38403]], camposKey:0005-2736 1979-01-01 Stimulation of monovalent cation fluxes by electron donors in the human red cell membrane118130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38404]], camposKey:0005-2736 1978-01-01 Use of salicylic acid to measure the apparent intracellular pH in the ehrlich ascites-tumor cell and Escherichia coli148158, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38407]], camposKey:0005-2736 1977-01-01 Free carboxylate groups required for transport of neutral amino acids by the Ehrlich ascites-tumor cell426428, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38408]], camposKey:0005-2736 1977-01-01 Role of proton dissociation in the transport of acidic amino acids by the Ehrlich ascites tumor cells295312, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38409]], camposKey:0027-8424 1977-01-01 Unexpected additional mode of energization of amino acid transport into Ehrlich cells14881491][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19709]},camposKey: 259 276 Reparación cardíaca con células madre 8493689068Células madre y terapia regenerativa 1 2009-01-01 Real Academia Nacional de Farmacia , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17242]},camposKey: 187 201 Autologous mononuclear bone marrow transplantation for myocardial infarction: The Spanish experience 978-0-387-30939-2Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair: From Basic Research to Clinical Applications 1 2006-01-01 Springer US, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17243]},camposKey: 121 134 Progenitor cells for cardiac regeneration 978-0-387-30939-2Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair: From Basic Research to Clinical Applications 1 2006-01-01 Springer US][][][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=61925]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62692]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56685]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=61925]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62692]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=56685]]][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145631576]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638426]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145633598]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145633763]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145631529]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145633542]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626851]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626842]]][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c5485, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c558b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c5595, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c537f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c54c6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c478e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c5691, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c5696, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c5611, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c5885, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c5610, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c53ed, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c483a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c53f3, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c4c66, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c483b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c4871, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c53f0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c478d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c4839, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c50f1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c4901, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c5119, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372593, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c529f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372398, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372150, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c5180, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4c50e2][][][][][][com.sigma.fs3.argos.domain.gpc.GpcPatents[id=com.sigma.fs3.argos.domain.gpc.GpcPatentsPK[ifcactivitat=PAT, ifccomptador=1266]]][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c28], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c27], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@466ff6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4132af], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412fcd], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4130b8], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125ce], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413be7], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411f8d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56465f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@46087e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41235d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4121f4], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4122e8], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4605ea], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411db0], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4604c6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411ee5], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f3f7], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411bef], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f480], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41255d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4134b9], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413ad8]][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1436b, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14366][]

PUBLICACIONES

Artículos de revista (77)

Aparicio C.; Belver M.; Enriquez L.; Espeso F.; Nuñez L.; Sanchez A.; de la Fuente M.A.; Gonzalez-Vallinas M. Cell therapy for colorectal cancer: The promise of chimeric antigen receptor (car)¿t cells . International Journal of Molecular Sciences 2021; 22(21).

Enlace a la publicación
Ver Todos

Capítulos de libros (3)

Sanchez Garcia, Ana; Garcia Sancho, Javier. Reparación cardíaca con células madre. En: -. Células madre y terapia regenerativa. Real Academia Nacional de Farmacia 2009. p. 259-276.


Ver Todos
 

AYUDA A LA INVESTIGACIÓN

Proyectos (24)

EQUIPO DE IMAGEN POR RESONANCIA MAGNÉTICA PARA USO EN INVESTIGACIÓN PLURIDISCIPLINAR (BIOMÉDICA Y NO BIOMÉDICA) PARA ESTUDIO DE MODELOS ANIMALES EXPERIMENTALES Y OTRO TIPO DE MUESTRAS NO BIOLÓGICAS. Equipo Investigadores: RODRIGUEZ CABELLO, JOSE CARLOS (IP); SANCHEZ GARCIA, ANA MARIA DE LOS ANGELES; CALONGE CANO, MARGARITA; MANSO ALONSO, MARIA TERESA; MUÑOZ TORRE, RAUL; HORNERO SANCHEZ, ROBERTO. EQC2021-007278-P. Entidades Participantes: UNIVERSIDAD DE VALLADOLID (UVa). Entidades Financiadoras: AGENCIA ESTATAL DE INVESTIGACIÓN, UNIÓN EUROPEA.-NEXT GENERATION UE, ESPAÑA PUEDE, PLAN DE RECUPERACIÓN, TRANSFORMACIÓN Y RESILIENCIA, MICINN. MINISTERIO DE CIENCIA E INNOVACIÓN . 01/01/2022-31/12/2023

AEINext Generation-UEMnisterio de Ciencia e InnovaciónEspaña PuedePlan de Recuperación, transformación y Resiliencia
Ver Todos

Convenios (29)

CENTRO EN RED DE MEDICINA REGENERATIVA Y TERAPIA CELULAR DE CYL. . Equipo Investigadores: NUÑEZ LLORENTE, LUCIA (IP); SANCHEZ GARCIA, ANA MARIA DE LOS ANGELES (IP). Entidades Participantes: FUNDACION GENERAL DE LA UNIVERSIDAD DE VALLADOLID.. Entidades Financiadoras: JUNTA DE CASTILLA Y LEÓN.. 2022-01-01

Ver Todos

Otras ayudas y becas (3)

UNIVERSIDAD DE VALLADOLID (UVa). CONTRATO POSTDOCTORAL UVA DE GONZÁLEZ-VALLINAS GARRACHÓN, MARGARITA: "DESARROLLO DE CÉLULAS CARTALOGÉNICAS CONTRA LIGANDOS DE NKG2D". SANCHEZ GARCIA, ANA MARIA DE LOS ANGELES (Director). GONZÁLEZ-VALLINAS GARRACHÓN, MARGARITA (Beneficiario). 01/06/2021 - 31/05/2024. 98.550,00 EUR.

Universidad de Valladolid
Ver Todos
 

OTROS

Tesis doctorales (8)


Texto completo en acceso abierto  
Ver Todos

Patentes (1)

Ana Sánchez García, Javier García-Sancho Martín, Verónica García Díaz, Mercedes Alberca Zaballos, Method for obtaining an enriched population of functional mesenchymal stem cells, cells obtained thereof and compositions comprrising the same. EP18382679.1. 2019
Ver Todos
Cargando información ...
Universidad de Valladolid - Copyright Universidad de Valladolid - Todos los derechos reservados